Found: 38
Select item for more details and to access through your institution.
Primary subcutaneous Alternaria alternata infection of the hand in an immunocompromised host.
- Published in:
- Medical Mycology, 2011, v. 49, n. 5, p. 543, doi. 10.3109/13693786.2011.555848
- By:
- Publication type:
- Article
Engineered T Cells: CAR T Cell Therapy and Beyond.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 1, p. 23, doi. 10.1007/s11912-021-01161-4
- By:
- Publication type:
- Article
Phase IA/ II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non- Hodgkin or Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 2, p. 258, doi. 10.1111/bjh.12630
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia patients with chromosome 6q deletion as the sole cytogenetic abnormality display a high frequency of RPS15 mutations and have a poor prognosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1845, doi. 10.1002/ajh.27421
- By:
- Publication type:
- Article
Efficacy and safety of CD19‐directed CAR‐T cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the JULIET, ZUMA‐1, and TRANSCEND trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 10, p. 1295, doi. 10.1002/ajh.26301
- By:
- Publication type:
- Article
Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas.
- Published in:
- Oncology (08909091), 2022, v. 36, n. 8, p. 499
- By:
- Publication type:
- Article
Adult T-cell Leukemia/Lymphoma: Complexities in Diagnosis and Novel Treatment Strategies.
- Published in:
- Oncology (08909091), 2009, v. 23, n. 14, p. 1267
- By:
- Publication type:
- Article
Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 6, p. 528, doi. 10.1001/jama.2023.11887
- By:
- Publication type:
- Article
Tips on Choosing a CAR T-Cell Therapy in DLBCL.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 11, p. 592
- By:
- Publication type:
- Article
Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Unanswered Questions in HIV Hematology.
- Published in:
- Advances in Hematology, 2012, p. 1, doi. 10.1155/2012/907025
- By:
- Publication type:
- Article
HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.
- Published in:
- Advances in Hematology, 2012, p. 1, doi. 10.1155/2012/507257
- By:
- Publication type:
- Article
Small-cell predominant extranodal NK/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western population.
- Published in:
- Histopathology, 2016, v. 69, n. 4, p. 667, doi. 10.1111/his.12990
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e300, doi. 10.1016/j.clml.2021.10.018
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 4, p. e250, doi. 10.1016/j.clml.2021.10.004
- By:
- Publication type:
- Article
Treatment of Relapsed DLBCL.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S165, doi. 10.1016/j.clml.2017.08.075
- By:
- Publication type:
- Article
Transformative Clinical Trials in Non-Hodgkin and Hodgkin Lymphomas.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 10, p. 1, doi. 10.1038/s41408-022-00741-2
- By:
- Publication type:
- Article
Metabolic parameters predict survival and toxicity in chimeric antigen receptor T‐cell therapy‐treated relapsed/refractory large B‐cell lymphoma.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 1, p. 1, doi. 10.1002/hon.3231
- By:
- Publication type:
- Article
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
- By:
- Publication type:
- Article
Panobinostat in combination with rituximab in heavily pretreated diffuse large B-cell lymphoma: Results of a phase II study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcome.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 10, p. E436, doi. 10.1002/ajh.24485
- By:
- Publication type:
- Article
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. 395, doi. 10.1002/ajh.24299
- By:
- Publication type:
- Article
De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 4, p. 395, doi. 10.1002/ajh.24299
- By:
- Publication type:
- Article
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: Characteristics, outcomes, and prognostication among a large multicenter cohort.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 9, p. 778, doi. 10.1002/ajh.24082
- By:
- Publication type:
- Article
Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 6, p. 529, doi. 10.1002/ajh.24008
- By:
- Publication type:
- Article
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Hitting back at lymphoma: How do modern diagnostics identify high-risk diffuse large B-cell lymphoma subsets and alter treatment?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 3, p. 423, doi. 10.1002/cncr.29066
- By:
- Publication type:
- Article
Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 11, p. 2580, doi. 10.1002/cncr.25788
- By:
- Publication type:
- Article
Intravenous Methotrexate as Central Nervous System (CNS) Prophylaxis Is Associated With a Low Risk of CNS Recurrence in High-Risk Patients With Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 18, p. 4283, doi. 10.1002/cncr.25278
- By:
- Publication type:
- Article
The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas.
- Published in:
- British Journal of Haematology, 2009, v. 144, n. 3, p. 358, doi. 10.1111/j.1365-2141.2008.07484.x
- By:
- Publication type:
- Article
Diffuse Large B-Cell Lymphoma Treated With R-CHOP in a Resource-Limited Setting in South Africa: A Real-World Study.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. e756, doi. 10.1093/oncolo/oyad069
- By:
- Publication type:
- Article
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 12, p. 2239, doi. 10.1093/neuonc/noad118
- By:
- Publication type:
- Article
Optimal Antiviral Prophylaxis Against Hepatitis B Reactivation in Patients Receiving Rituximab-Based Chemotherapy for Lymphoma.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
R-CHOP: Does One Size Fit All in Diffuse Large B Cell Lymphoma?
- Published in:
- Acta Haematologica, 2014, v. 131, n. 3, p. 153, doi. 10.1159/000355325
- By:
- Publication type:
- Article
Small volume biopsy diagnostic yield at initial diagnosis versus recurrence/transformation of follicular lymphoma: A retrospective Cyto‐Heme Interinstitutional Collaborative study.
- Published in:
- Cancer Cytopathology, 2023, v. 131, n. 5, p. 279, doi. 10.1002/cncy.22676
- By:
- Publication type:
- Article